Blog - Page 79 of 5672 - QualityStocks

TuesdayMar 31, 2026 12:05 pm

QualityStocksNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Invests in Space Robotics Startup General Astronautics at $40 Million Valuation

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising. Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced a $100,000 strategic investment in General Astronautics, a space robotics company selected for Y Combinator’s Winter 2026 cohort, at a $40 million post-money valuation. The company said General Astronautics is developing autonomous robotic systems for microgravity environments to enable scalable research and manufacturing in space, targeting applications across biotechnology, pharmaceuticals, advanced materials and semiconductors, while positioning the investment as part of its strategy to back high-impact, frontier technologies. To view the full press release, visit https://ibn.fm/hjtY4 About Planet Ventures Inc. Planet Ventures Inc.…

TuesdayMar 31, 2026 11:52 am

QualityStocksNewsBreaks – Fairchild Gold (TSX.V: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) Transitions To Semi-Annual Financial Reporting Under TSXV Pilot Program

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising. Fairchild Gold (TSX.V: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) announced it will adopt a semi-annual financial reporting framework under Coordinated Blanket Order 51-933, allowing the company to forgo first- and third-quarter filings while continuing to report audited annual results and mid-year financials. The company said it qualifies for the program as a TSX Venture Exchange-listed issuer with less than $10 million in annual revenue and a clean 12-month disclosure record, with updated reporting timelines beginning in fiscal 2026. To view the press release, visit https://ibn.fm/0x851 About Fairchild Gold Corp. Fairchild Gold Corp. is a…

TuesdayMar 31, 2026 11:15 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

LIXTE’s lead compound, LB-100, is the world’s first and only clinical-stage inhibitor of protein phosphatase 2A (“PP2A”). LB-100 helps in the fight against cancer in a few ways, as it makes cancer cells more sensitive to immunotherapy and chemotherapy, while also disrupting cancer’s internal repair system. The compound has demonstrated a favorable safety profile in Phase 1 clinical trials and has been supported by over 25 published preclinical and translational studies so far. LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100.…

TuesdayMar 31, 2026 11:00 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Reports Q4 2025 Revenue Growth of 127% and Expands Blockchain-Based Mortgage Platform

Beeline Holdings (NASDAQ: BLNE) reported fourth-quarter 2025 net revenue of $2.5 million, up 127% year over year, on origination volume of $84.7 million, a 44% increase, as the company continued improving loan economics with a 31% rise in average revenue per loan and an 18% reduction in cost per loan. The company also launched its BeelineEquity platform, closing initial blockchain-recorded transactions, while ending the year debt-free and positioning for scalable growth, with management highlighting progress toward cash flow break-even and a long-term goal of reaching a $100 million revenue run rate. To view the full press release, visit https://ibn.fm/A5Syt About Beeline Holdings, Inc.  Beeline is a next-generation…

TuesdayMar 31, 2026 10:30 am

GPS-Denied Navigation Isn’t Just a Problem for the Future, It’s Happening Right Now

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. GPS jamming has emerged as a key modern warfare tactic, using high-powered radio signals to disrupt satellite navigation and shape both offensive operations and defensive countermeasures on the battlefield. This sparks major concern for many organizations and military forces, as several aspects of war rely on GPS, such as tracking, navigation, communication, and others. To fight back against GPS jamming, companies like SPARC AI have created GPS-free technology to deliver real-time insights, detection, and tracking, without having to rely on radar, lidar, and sensors.…

TuesdayMar 31, 2026 10:20 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches $100 Million Copper Tokenization Initiative With Coppercore

Datavault AI (NASDAQ: DVLT) announced the closing of a definitive agreement with Coppercore Inc. to digitize and tokenize copper resources through its proprietary blockchain platform, targeting the creation of $100 million or more in Coppercoin(TM) digital tokens. Each token will represent five pounds of in-ground copper with pricing linked to COMEX benchmarks, enabling fractional, liquid ownership for global investors, as the company positions the initiative to launch by the end of the second quarter and expand access to the growing copper market tied to AI infrastructure, electrification and energy transition demand. To view the full press release, visit https://ibn.fm/3Uy1v About…

TuesdayMar 31, 2026 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Expands Pipeline Momentum as SGX945 Earns Global Recognition

In the life sciences industry, a robust pipeline is widely recognized as a critical driver of value creation and sustainability. The significance of the UK designation extends beyond a single program. The UK designation builds on additional regulatory recognition for dusquetide, including orphan drug designation from the FDA for Behçet’s disease. A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development…

TuesdayMar 31, 2026 9:30 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with interim analysis expected in Q2 2026 and top-line results anticipated in the second half of the year. The company also noted regulatory momentum with orphan drug designation for dusquetide in Behçet’s Disease, ongoing development of SGX302 and SGX945 programs and a year-end cash position of approximately $7.9 million, as it continues to pursue strategic options to support late-stage development. To view the full press release, visit https://ibn.fm/b1p2y About Soligenix Soligenix is a late-stage…

TuesdayMar 31, 2026 9:20 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch

Nutriband (NASDAQ: NTRB) announced it has selected a proposed worldwide brand name for its abuse-deterrent fentanyl transdermal system, with plans to submit the name and product labeling to the FDA and international regulators as well as file for trademark protection. The company said the product, developed using its AVERSA(TM) technology, could become the first abuse-deterrent fentanyl patch designed to reduce misuse and accidental exposure, targeting a potential peak annual U.S. market of $80 million to $200 million while addressing broader global pain management needs. To view the full press release, visit https://ibn.fm/QBBSF About Nutriband Inc. We are primarily engaged in the…

TuesdayMar 31, 2026 9:10 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Advances Multi-Project Exploration Portfolio Following $10.2 Million Financing

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) provided an update on exploration across its seven-project portfolio spanning Brazil, the United States and Canada, highlighting ongoing REE drilling at its Turvolândia and Patos projects in Brazil, geophysical modelling at the Iron Hills project in Colorado and advancing technical and permitting work across three Ontario assets. The company also reported raising approximately $10.2 million over the past four months, positioning it to execute near-term exploration programs and support continued portfolio expansion, with multiple…

Site Search

Company Search